Suppr超能文献

甲状腺功能亢进症患者血清血管紧张素转换酶活性升高。

Elevation of serum angiotensin-converting enzyme activity in patients with hyperthyroidism.

作者信息

Nakamura Y, Takeda T, Ishii M, Nishiyama K, Yamakada M, Hirata Y, Kimura K, Murao S

出版信息

J Clin Endocrinol Metab. 1982 Nov;55(5):931-4. doi: 10.1210/jcem-55-5-931.

Abstract

The activity of serum angiotensin-converting enzyme (S-ACE) was determined spectrophotometrically in 45 patients with hyperthyroidism (30 untreated and 15 treated and euthyroid patients), 14 patients with hypothyroidism, and 135 normotensive healthy subjects. S-ACE was significantly higher in the patients with untreated hyperthyroidism (51.6 +/- 1.9 less than SE greater than nmol.min/ml) than in the healthy controls (28.6 +/- 0.6 nmol.min/ml; P less than 0.001). On the other hand, S-ACE was found to be within the normal range in patients with hypothyroidism (23.2 +/- 1.3 nmol.min/ml). In patients with hyperthyroidism, S-ACE gradually fell into the normal range as the thyroid function became normalized, and there were significant positive correlations between S-ACE and the plasma T3 or T4 concentration (r = 0.60 and P less than 0.001; r = 0.61 and P less than 0.001, respectively ). S-ACE had no definite relation to blood pressure, serum glutamic oxaloacetic acid transaminase, or glutamic pyruvic acid transaminase. When the physicochemical characteristics of the enzyme in the sera of hyperthyroidism patients were compared with those in sarcoidosis patients, similar peak activities of S-ACE on gel chromatography and identical Michaelis constants were obtained; the effects of ethyldiaminetetraacetic acid, SQ14225, and pH on the enzymatic reaction were also similar in both diseases. Thus, hyperthyroidism is considered to be one of the diseases in which S-ACE is elevated. The elevation of S-ACE might be directly or indirectly related to the hyperthyroid state. In addition, it is suggested that the enzyme characteristics are identical in hyperthyroidism and sarcoidosis.

摘要

采用分光光度法测定了45例甲状腺功能亢进患者(30例未经治疗,15例经治疗后甲状腺功能正常)、14例甲状腺功能减退患者和135例血压正常的健康受试者血清血管紧张素转换酶(S-ACE)的活性。未经治疗的甲状腺功能亢进患者的S-ACE活性(51.6±1.9[小于标准误大于]nmol·min/ml)显著高于健康对照组(28.6±0.6 nmol·min/ml;P<0.001)。另一方面,甲状腺功能减退患者的S-ACE活性在正常范围内(23.2±1.3 nmol·min/ml)。在甲状腺功能亢进患者中,随着甲状腺功能恢复正常,S-ACE逐渐降至正常范围,且S-ACE与血浆T3或T4浓度之间存在显著正相关(r分别为0.60,P<0.001;r为0.61,P<0.001)。S-ACE与血压、血清谷草转氨酶或谷丙转氨酶无明确关系。当比较甲状腺功能亢进患者血清中该酶的理化特性与结节病患者血清中该酶的理化特性时,在凝胶色谱上获得了相似的S-ACE峰值活性,且米氏常数相同;在两种疾病中,乙二胺四乙酸、SQ14225和pH对酶促反应的影响也相似。因此,甲状腺功能亢进被认为是S-ACE升高的疾病之一。S-ACE的升高可能与甲状腺功能亢进状态直接或间接相关。此外,提示甲状腺功能亢进和结节病中该酶的特性相同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验